1742-4690-11-S1-P99 1742-4690 Poster presentation <p>Comparative infection of autologous primary T cells and monocytes derived DCs using cell-free virus preparation, viral biofilm, pseudotyped-virus or viral synapse</p> AlaisSandrine DutartreHélène MahieuxRenaudrenaud.mahieux@ens-lyon.fr

Oncogenèse Rétrovirale, label « Ligue Nationale Contre le Cancer », CIRI, Labex Ecofect, INSERM U1111-CNRS UMR5308, Université Lyon-1, Ecole Normale Supérieure, Lyon, Cedex 07, France

Retrovirology <p>16th Interntional Conference on Human Retroviruses: HTLV and Related Viruses</p>Benoit BarbeauMeeting abstracts<p>16th International Conference on Human Retroviruses: HTLV and Related Viruses</p>Montreal, Canada26-30 June 2013http://www.htlv2013.com/1742-4690 2014 11 Suppl 1 P99 http://www.retrovirology.com/content/11/S1/P99 10.1186/1742-4690-11-S1-P99
712014 2014Alais et al; licensee BioMed Central Ltd.This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

HTLV-1 infected T cells and blood dentritic cells (DCs) can be found in HTLV-1 carriers. It is currently believed that T cell infection requires cell-cell contact, while DCs could also be infected with cell-free virus. However, a comparative study using different modes of viral preparation for infecting human primary autologous T and DC cells has not been performed. Supernatant from HTLV-1 chronically infected T cells, cell conjugates between HTLV-1 infected cells and target cells, or purified viral biofilm were used side-by-side to infect autologous human primary lymphocytes and monocytes-derived dendritic cells. To monitor the early steps of viral infection, we also used pseudotyped viruses carrying either the HTLV-1 or the VSV envelopes. Infection was then followed by flow cytometry, ELISA, immunofluorescence, real-time PCR and alu-PCR. Our first data show that, depending on the source of viruses, lymphocytes have distinct susceptibility to HTLV-1 infection. The impact of the viral source in the spread of HTLV-1 infection will be discussed.